HT 7.34 Hersha Hospitality Trust $HT Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
HT 7.34 Hersha Hospitality Trust $HT Hit a 52 week high of 7.44 Currently at 7.34 -0.03 -0.41% With a day low of 7.31 and a total volume of 1,858,000.

HT Hersha Hospitality Trust Recent Headline News

Shares of HT Up 24.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 03, 4:39PM CST
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 8 months, Hersha Hospitality Trust has returned 24.23% as of today's recent price of $7.28.
HT: 7.34 (-0.03)

Hersha Hospitality reports 3Q results
Automated Insights - Wed Oct 29, 5:12PM CDT
HARRISBURG, Pa. (AP) _ Hersha Hospitality Trust (HT) on Wednesday reported a key measure of profitability in its third quarter. The results beat Wall Street expectations.
HT: 7.34 (-0.03)

Hersha Hospitality Trust Announces Third Quarter 2014 Results
Business Wire - Wed Oct 29, 4:00PM CDT
--- Comparable Hotel EBITDA Margins Increase 150 bps -
HT: 7.34 (-0.03)

Should You Buy Hersha Hospitality (HT) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 7:42AM CDT
Hersha Hospitality has a positive Earnings ESP and a favorable Zacks Rank, suggesting that stock is poised to beat at the next earnings season.
HT: 7.34 (-0.03)

Hersha Hospitality Trust Shares Up 18.6% Since SmarTrend's Buy Recommendation (HT)
Comtex SmarTrend(R) - Mon Oct 27, 10:59AM CDT
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 8 months, Hersha Hospitality Trust has returned 18.60% as of today's recent price of $6.95.
HT: 7.34 (-0.03)

Hersha Hospitality Trust Up 12.8% Since SmarTrend Uptrend Call (HT)
Comtex SmarTrend(R) - Mon Oct 20, 10:01AM CDT
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 8 months, Hersha Hospitality Trust has returned 12.80% as of today's recent price of $6.61.
HT: 7.34 (-0.03)

12.5% Return Seen to Date on SmarTrend Hersha Hospitality Trust Call (HT)
Comtex SmarTrend(R) - Thu Oct 09, 11:16AM CDT
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 7 months, Hersha Hospitality Trust has returned 12.46% as of today's recent price of $6.59.
HT: 7.34 (-0.03)

Hersha Hospitality Trust Hosts Investor Day and Announces Preliminary Third Quarter 2014 Results
Business Wire - Wed Oct 08, 6:00AM CDT
Hersha Hospitality Trust (NYSE: HT) ("Hersha" or the "Company", owner of upscale hotels in urban gateway markets, will host an Investor Day today from 10:00 a.m. - 2:00 p.m. at The Rittenhouse in Philadelphia, PA. The Investor Day's presentations will be streamed live via webcast at www.hersha.com within the "Investor Relations" section.
HT: 7.34 (-0.03)

Hersha Hospitality Trust to Report Third Quarter 2014 Earnings on October 29, 2014
Business Wire - Wed Oct 01, 7:00AM CDT
Hersha Hospitality Trust (NYSE: HT) ("Hersha", the "Company", owner of upscale hotels in urban gateway markets, announced that the Company will release its financial results for the third quarter 2014 after the market close on Wednesday, October 29, 2014. The Company will host a conference call to discuss these results at 9:00 a.m. Eastern Time on Thursday, October 30, 2014. Hosting the call will be Mr. Jay H. Shah, Chief Executive Officer, Mr. Neil H. Shah, President and Chief Operating Officer, and Mr. Ashish Parikh, Chief Financial Officer.
HT: 7.34 (-0.03)

Hersha (HT) Hikes Dividend by 16.7% on Cash Flow Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 12:40PM CDT
Hersha Hospitality Trust (HT) raised its quarterly cash dividend by 16.7% to 7 cents per share from 6 cents paid earlier.
CLDT: 25.60 (-0.40), RLJ: 31.74 (-0.29), DRH: 14.10 (-0.09), HT: 7.34 (-0.03)

Hersha Hospitality Trust Announces Increase In Quarterly Dividend
Business Wire - Mon Sep 22, 7:01AM CDT
Hersha Hospitality Trust (NYSE: HT) ("Hersha" or the "Company", owner of upscale hotels in urban gateway markets, today announced that its Board of Trustees declared an increased quarterly cash dividend of $0.07 per Common Share and per Limited Partnership Unit for the third quarter ending September 30, 2014. The increased dividend represents an annualized run rate of $0.28 per share and a 4.3% yield based on the closing share price on September 19, 2014.
HT: 7.34 (-0.03)

Uptrend Call Working As Hersha Hospitality Trust Stock Rises 13.8% (HT)
Comtex SmarTrend(R) - Thu Sep 11, 5:07PM CDT
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 6 months, Hersha Hospitality Trust has returned 13.82% as of today's recent price of $6.67.
HT: 7.34 (-0.03)

Hersha Hospitality Trust to Host Institutional Investor Day October 8, 2014 in Philadelphia, PA
Business Wire - Wed Sep 10, 3:00PM CDT
Hersha Hospitality Trust (NYSE: HT) ("Hersha", the "Company", owner of upscale hotels in urban gateway markets, announced that the Company will host an Institutional Investor Day at The Rittenhouse in Philadelphia, PA on Wednesday, October 8, 2014.
HT: 7.34 (-0.03)

Shares of HT Up 16.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Sep 04, 11:09AM CDT
SmarTrend identified an Uptrend for Hersha Hospitality Trust (AMEX:HT) on March 5th, 2014 at $5.86. In approximately 6 months, Hersha Hospitality Trust has returned 16.89% as of today's recent price of $6.85.
HT: 7.34 (-0.03)

Analyst Scanner on REITs Equities -- DiamondRock Hospitality, Hersha Hospitality Trust, LaSalle Hotel Properties, iStar Financial, and National Retail Properties
PR Newswire - Wed Aug 27, 8:10AM CDT
On Tuesday, August 26, 2014, the NASDAQ Composite ended at 4,570.64, up 0.29%, the Dow Jones Industrial Average edged 0.17% higher to finish the day at 17,106.70, and the S&P 500 closed at 2,000.02, up 0.11%. The gains were broad based with seven out of ten sectors ending the session in positive. The S&P 500 Financials Sector Index ended the day at 314.22, up 0.26%, with the index advancing 6.06% in the previous three months. Investor-Edge has initiated coverage on the following equities: DiamondRock Hospitality Company (NYSE: DRH), Hersha Hospitality Trust (NYSE: HT), LaSalle Hotel Properties (NYSE: LHO), iStar Financial Inc. (NYSE: STAR), and National Retail Properties Inc. (NYSE: NNN). Free research on these five companies can be accessed at:
STAR: 14.37 (+0.12), NNN: 38.41 (+0.17), LHO: 38.89 (-0.23), HT: 7.34 (-0.03), DRH: 14.10 (-0.09)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading